259 related articles for article (PubMed ID: 15358010)
1. Therapeutic update: non-selective beta- and alpha-adrenergic blockade in patients with coexistent chronic obstructive pulmonary disease and chronic heart failure.
Sirak TE; Jelic S; Le Jemtel TH
J Am Coll Cardiol; 2004 Aug; 44(3):497-502. PubMed ID: 15358010
[TBL] [Abstract][Full Text] [Related]
2. Differences between beta-blockers in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized crossover trial.
Jabbour A; Macdonald PS; Keogh AM; Kotlyar E; Mellemkjaer S; Coleman CF; Elsik M; Krum H; Hayward CS
J Am Coll Cardiol; 2010 Apr; 55(17):1780-7. PubMed ID: 20413026
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic and therapeutic challenges in patients with coexistent chronic obstructive pulmonary disease and chronic heart failure.
Le Jemtel TH; Padeletti M; Jelic S
J Am Coll Cardiol; 2007 Jan; 49(2):171-80. PubMed ID: 17222727
[TBL] [Abstract][Full Text] [Related]
4. Differences between bisoprolol and carvedilol in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized trial.
Lainscak M; Podbregar M; Kovacic D; Rozman J; von Haehling S
Respir Med; 2011 Oct; 105 Suppl 1():S44-9. PubMed ID: 22015086
[TBL] [Abstract][Full Text] [Related]
5. Impact of β-blocker selectivity on long-term outcomes in congestive heart failure patients with chronic obstructive pulmonary disease.
Kubota Y; Asai K; Furuse E; Nakamura S; Murai K; Tsukada YT; Shimizu W
Int J Chron Obstruct Pulmon Dis; 2015; 10():515-23. PubMed ID: 25784798
[TBL] [Abstract][Full Text] [Related]
6. Exchange of beta-blockers in heart failure patients. Experiences from the poststudy phase of COMET (the Carvedilol or Metoprolol European Trial).
Di Lenarda A; Remme WJ; Charlesworth A; Cleland JG; Lutiger B; Metra M; Komajda M; Torp-Pedersen C; Scherhag A; Swedberg K; Poole-Wilson PA;
Eur J Heart Fail; 2005 Jun; 7(4):640-9. PubMed ID: 15921806
[TBL] [Abstract][Full Text] [Related]
7. Cardio-selective and non-selective beta-blockers in chronic obstructive pulmonary disease: effects on bronchodilator response and exercise.
Chang CL; Mills GD; McLachlan JD; Karalus NC; Hancox RJ
Intern Med J; 2010 Mar; 40(3):193-200. PubMed ID: 19383058
[TBL] [Abstract][Full Text] [Related]
8. Selective versus nonselective beta-adrenergic receptor blockade in chronic heart failure: differential effects on myocardial energy substrate utilization.
Al-Hesayen A; Azevedo ER; Floras JS; Hollingshead S; Lopaschuk GD; Parker JD
Eur J Heart Fail; 2005 Jun; 7(4):618-23. PubMed ID: 15921803
[TBL] [Abstract][Full Text] [Related]
9. Coexistent chronic obstructive pulmonary disease and heart failure in the elderly.
Padeletti M; Jelic S; LeJemtel TH
Int J Cardiol; 2008 Apr; 125(2):209-15. PubMed ID: 18221802
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological modulation of beta-adrenoceptor function in patients with coexisting chronic obstructive pulmonary disease and chronic heart failure.
Matera MG; Martuscelli E; Cazzola M
Pulm Pharmacol Ther; 2010 Feb; 23(1):1-8. PubMed ID: 19833222
[TBL] [Abstract][Full Text] [Related]
11. [COPD patients with heart failure: no concern about the beta blocker!].
Stiefelhagen P
MMW Fortschr Med; 2012 Apr; 154(6):26. PubMed ID: 22642023
[No Abstract] [Full Text] [Related]
12. Comparative effects of carvedilol and metoprolol on regional vascular responses to adrenergic stimuli in normal subjects and patients with chronic heart failure.
Hryniewicz K; Androne AS; Hudaihed A; Katz SD
Circulation; 2003 Aug; 108(8):971-6. PubMed ID: 12912816
[TBL] [Abstract][Full Text] [Related]
13. Heart failure and chronic obstructive pulmonary disease the quandary of Beta-blockers and Beta-agonists.
Hawkins NM; Petrie MC; Macdonald MR; Jhund PS; Fabbri LM; Wikstrand J; McMurray JJ
J Am Coll Cardiol; 2011 May; 57(21):2127-38. PubMed ID: 21596228
[TBL] [Abstract][Full Text] [Related]
14. [Differences among beta-blockers for the treatment of patients with heart failure and chronic obstructive pulmonary disease].
Di Tano G; Frattini S; Pirelli S
G Ital Cardiol (Rome); 2011 Sep; 12(9):588-95. PubMed ID: 21892219
[TBL] [Abstract][Full Text] [Related]
15. The evaluation of β-adrenoceptor blocking agents in patients with COPD and congestive heart failure: a nationwide study.
Liao KM; Lin TY; Huang YB; Kuo CC; Chen CY
Int J Chron Obstruct Pulmon Dis; 2017; 12():2573-2581. PubMed ID: 28894360
[TBL] [Abstract][Full Text] [Related]
16. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group.
Packer M; Bristow MR; Cohn JN; Colucci WS; Fowler MB; Gilbert EM; Shusterman NH
N Engl J Med; 1996 May; 334(21):1349-55. PubMed ID: 8614419
[TBL] [Abstract][Full Text] [Related]
17. Beta-blockers in heart failure. Do they improve the quality as well as the quantity of life?
Fowler MB
Eur Heart J; 1998 Dec; 19 Suppl P():P17-25. PubMed ID: 9886708
[TBL] [Abstract][Full Text] [Related]
18. Low-dose carvedilol improves left ventricular function and reduces cardiovascular hospitalization in Japanese patients with chronic heart failure: the Multicenter Carvedilol Heart Failure Dose Assessment (MUCHA) trial.
Hori M; Sasayama S; Kitabatake A; Toyo-oka T; Handa S; Yokoyama M; Matsuzaki M; Takeshita A; Origasa H; Matsui K; Hosoda S;
Am Heart J; 2004 Feb; 147(2):324-30. PubMed ID: 14760332
[TBL] [Abstract][Full Text] [Related]
19. Beta-receptor selectivity of carvedilol and metoprolol succinate in patients with heart failure (SELECT trial): a randomized dose-ranging trial.
Zebrack JS; Munger M; Macgregor J; Lombardi WL; Stoddard GP; Gilbert EM
Pharmacotherapy; 2009 Aug; 29(8):883-90. PubMed ID: 19637941
[TBL] [Abstract][Full Text] [Related]
20. Commentary on the Carvedilol or Metoprolol European Trial (COMET).
Poole-Wilson PA
Am J Cardiol; 2004 May; 93(9A):40B-2B. PubMed ID: 15144936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
